MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q2
hinzugefügt 13.05.2026
Veru P/S 2011-2026 | VERU
P/S Jährlich Veru
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.639 | 6.15 | 12.3 | 6.23 | 3.95 | 3.94 | 4.21 | 3.09 | 1.23 | 1.5 | 5.33 | 8.63 | 5.36 | 6.4 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 12.3 | 0.639 | 4.92 |
P/S anderer Aktien in der Arzneimittelhersteller
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Cumberland Pharmaceuticals
CPIX
|
6.2 | $ 5.87 | 6.53 % | $ 87.2 M |  USA |
 |
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
0.036 | - | - | $ 36.6 M | USA |
 |
HEXO Corp.
HEXO
|
1.44 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
1.44 K | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
12.3 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
5.02 | $ 2.74 | 0.37 % | $ 1.05 B | Canada |
 |
Harrow Health
HROW
|
7.1 | $ 33.0 | 0.12 % | $ 1.21 B | USA |
 |
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
4.24 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
0.598 | $ 2.66 | - | $ 337 M | USA |
 |
Pacira BioSciences
PCRX
|
5.13 | $ 23.35 | -0.55 % | $ 1.08 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | USA |
 |
Bausch Health Companies
BHC
|
0.198 | $ 5.47 | 0.37 % | $ 2 B | Canada |
 |
Canopy Growth Corporation
CGC
|
0.528 | $ 1.04 | -2.8 % | $ 112 M | Canada |
 |
Tilray
TLRY
|
1.9 | $ 5.29 | -3.11 % | $ 3.27 B | Canada |
 |
Solid Biosciences
SLDB
|
4.76 | $ 6.62 | 1.85 % | $ 579 M | USA |
 |
Aurora Cannabis
ACB
|
0.0941 | $ 3.46 | -2.81 % | $ 190 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 1.1 | 3.77 % | $ 1.37 M | USA |
 |
Jupiter Wellness
JUPW
|
3.37 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
0.942 | $ 1.12 | -0.88 % | $ 107 M | Canada |
 |
Evolus
EOLS
|
0.913 | $ 6.09 | -5.58 % | $ 393 M | USA |
 |
Sundial Growers
SNDL
|
0.0158 | $ 1.45 | -1.36 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
0.609 | $ 8.45 | 0.96 % | $ 433 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
0.187 | $ 0.76 | -2.32 % | $ 3.06 M | USA |
 |
Assertio Holdings
ASRT
|
0.635 | $ 23.44 | 0.3 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
1.06 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
1.71 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
1.84 | $ 0.73 | 3.0 % | $ 36.5 M | USA |
 |
PLx Pharma
PLXP
|
14.6 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
1.19 | $ 16.65 | 1.15 % | $ 19.4 B | USA |
 |
Zomedica Corp.
ZOM
|
5.45 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
933 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
0.488 | $ 0.79 | -2.06 % | $ 28.4 M | USA |
 |
China Pharma Holdings
CPHI
|
0.663 | $ 0.76 | -0.29 % | $ 3.26 M |  China |
 |
TherapeuticsMD
TXMD
|
7.62 | $ 2.12 | 0.47 % | $ 24.5 M | USA |